ARTEMIS DIERENARTSEN
ActiveSummary
ARTEMIS DIERENARTSEN has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €558,410 and a net result of €150,702. Equity has been growing by about 33% per year since 2018. Its solvency ranks better than 76% of 1,598 sector peers (NACE 75, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 14-09-2012 Normal situation
- Activity
- Veterinary services NACE 75000
- Joint committee
- 336 Paritair Comité voor de vrije beroepen · annual accounts 2023
- Establishment unit
- 2.213.602.554 2800 Mechelen, since 14-09-2012
- Financial year end
- 31 December
- Peppol
- Reachable since 11-12-2025
Board and ownership
- BOUVEZ Frederic Patrick Lydia Marie-GhislainDirector · until 2024
- CALIS LienDirector · until 2024
- ZENEBERGH VanessaDirector · until 2024
- Auditor
- Jo François
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €359,581
- ▲ 7.6%
- Turnover
- ≈ €720,000
- estimated
- Profit
- €150,702
- ▲ 13.8%
- Equity
- €558,410
- ▲ 35.3%
- Total assets
- €741,443
- ▲ 35.6%
- Employees on 31-12-2025
- 4
- ▲ 33.3%
Score breakdownlowers riskLiquidity: current ratio 5.67, cash €274,901Sector: Veterinary activities (NACE 75)Size: total assets €741,443Figures for financial year 2025 (filed on 12-06-2026)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 75, micro). It does better than 88% of them on solvency, 87% on liquidity, 66% on profitability and 73% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 40 days before the deadline. In the sector (NACE 75), the median for financial year 2024 was 6 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed 4 directors appointed, 3 directors resigningChanges of role: ZENEBERGH Vanessa, BOUVEZ Frederic Patrick Lydia Marie-Ghislain and CALIS Lien · Appointment: Jo François (company auditor) · Legal-form conversion: from coöperatieve vennootschap met beperkte aansprakelijkheid to private limited company
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as ARTEMIS DIERENARTSEN: veterinary services (NACE 75000). They are comparable in size and age: total assets between €681,000 and €866,000, founded between 2011 and 2015.
| Company | Total assets | Gross margin |
|---|---|---|
| ARTEMIS DIERENARTSEN Mechelen | €741,443 | €359,581 |
| SENGER-TASIAUX Marche-en-Famenne | €719,934 | €322,115 |
| HUISDIERCHIRURGIE-VERDONCK Boechout | €866,323 | €332,846 |
| DAP DESAEVER - THEYS Westerlo | €742,362 | €295,336 |
| Vetriplume Hoogstraten | €812,580 | €444,849 |
| DR. EMILIE SUDRAUD Kasterlee | €681,163 | €410,013 |
| Dierenartsencentrum De Meren Mol | €741,594 | €298,220 |
Key facts about ARTEMIS DIERENARTSEN
- What is the company number of ARTEMIS DIERENARTSEN?
- The company number of ARTEMIS DIERENARTSEN is 0848.809.485. The VAT number is the same number with BE in front: BE 0848.809.485.
- Where is ARTEMIS DIERENARTSEN based?
- The registered office is at Liersesteenweg 173, 2800 Mechelen.Company details
- What does ARTEMIS DIERENARTSEN do?
- According to the KBO register, the main activity is veterinary services (NACE 75000).
- What is the legal form of ARTEMIS DIERENARTSEN?
- The legal form of ARTEMIS DIERENARTSEN is Private limited company (BV).
- When was ARTEMIS DIERENARTSEN founded?
- ARTEMIS DIERENARTSEN was founded on 14-09-2012.
- Is ARTEMIS DIERENARTSEN still active?
- Yes, ARTEMIS DIERENARTSEN is an active enterprise in the KBO register.
- How many employees does ARTEMIS DIERENARTSEN have?
- ARTEMIS DIERENARTSEN had an average of 3.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does ARTEMIS DIERENARTSEN fall under?
- In its 2023 annual accounts, ARTEMIS DIERENARTSEN states joint committee 336 (Paritair Comité voor de vrije beroepen).
- What is the turnover of ARTEMIS DIERENARTSEN?
- The turnover in financial year 2025 is ≈ €720,000. This figure is estimated from the gross margin of €359,581 and 882 comparable companies of the same size. It probably lies between €500,000 and €1.0m. It is a rough estimate.
- Is ARTEMIS DIERENARTSEN profitable?
- In financial year 2025, ARTEMIS DIERENARTSEN made a profit of €150,702.
- Where can I find the annual accounts of ARTEMIS DIERENARTSEN?
- ARTEMIS DIERENARTSEN filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of ARTEMIS DIERENARTSEN due?
- ARTEMIS DIERENARTSEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.